Screening for Celiac Disease in a North American Population: Sequential Serology and Gastrointestinal Symptoms

Overview

Journal Am J Gastroenterol

Specialty Gastroenterology

Date 2011 Mar 3

PMID 21364545

Citations 61

Authors

Kent D Katz

Shahrooz Rashtak

Brian D Lahr

L Joseph Melton 3rd

Patricia K Krause

Kristine Maggi

Nicholas J Talley

Joseph A Murray

Affiliations

Soon will be listed here.

Abstract

Objectives: The prevalence of diagnosed celiac disease is <1 in 2,000 in the United States, but screening studies undertaken in European and other populations have revealed a much higher prevalence. The objective of this study was to determine the prevalence of celiac disease and the utility of screening in the general adult population of a geographically isolated area.

Methods: Serum tissue transglutaminase antibodies (tTG-IgA) were measured in volunteer health-care participants aged ≥ 18 years at the annual Casper, Wyoming, Blue Envelope Health Fair blood draw. Subjects with positive tTG-IgA tests had their endomysial IgA antibodies checked. Double positives were offered endoscopy with small bowel biopsy. All subjects completed a short gastrointestinal (GI) symptom questionnaire.

Results: A total of 3,850 residents of the Natrona County had serologic evaluation for celiac disease, 34 of whom tested positive for both tTG and endomysial antibody (EMA) IgA. Excluding three individuals with previous diagnosis of celiac disease, the overall prevalence of positive celiac serology in this community sample was 0.8%. All 31 subjects were offered a small bowel biopsy. Of the 18 biopsied subjects, 17 (94%) had at least partial villous atrophy. Symptoms that were reported by the fair attendees did not predict positivity.

Conclusions: Screening for celiac disease was widely accepted in this preventative health-care setting. Undiagnosed celiac disease affects 1 in 126 individuals in this Wyoming community. Most were asymptomatic or had atypical presentations. Serologic testing can readily detect this disease in a general population.

Citing Articles

Prevalence of vomiting and nausea and associated factors after chronic and acute gluten exposure in celiac disease.

Ahonen I, Laurikka P, Koskimaa S, Huhtala H, Lindfors K, Kaukinen K BMC Gastroenterol. 2023; 23(1):301.

PMID: 37674120 PMC: 10481613. DOI: 10.1186/s12876-023-02934-w.

Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.

Elwenspoek M, Thom H, Sheppard A, Keeney E, ODonnell R, Jackson J Health Technol Assess. 2022; 26(44):1-310.

PMID: 36321689 PMC: 9638887. DOI: 10.3310/ZUCE8371.

Population-based screening for celiac disease reveals that the majority of patients are undiagnosed and improve on a gluten-free diet.

Kvamme J, Sorbye S, Florholmen J, Halstensen T Sci Rep. 2022; 12(1):12647.

PMID: 35879335 PMC: 9314380. DOI: 10.1038/s41598-022-16705-2.

Celiac Disease Presenting in a Community-Based Gastroenterology Practice: Obesity and Bone Disease Are Common.

Roldan G, Jamot S, Kopec K, Charoen A, Leffler D, Feller E Dig Dis Sci. 2022; 68(3):860-866.

PMID: 35650415 DOI: 10.1007/s10620-022-07521-9.

Biochemical abnormalities among patients referred for celiac disease antibody blood testing in a primary health care setting.

Karhus L, Kriegbaum M, Grand M, Lind B, Mollehave L, Rumessen J Sci Rep. 2022; 12(1):6407.

PMID: 35437007 PMC: 9016061. DOI: 10.1038/s41598-022-10492-6.

References

Rubio-Tapia A, Kyle R, Kaplan E, Johnson D, Page W, Erdtmann F . Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009; 137(1):88-93. PMC: 2704247. DOI: 10.1053/j.gastro.2009.03.059. View

Carrington J, Hewitt C, Dowsett L, Barbezat G . The prevalence of coeliac disease in Otago. N Z Med J. 1987; 100(828):460-2. View

Kurppa K, Collin P, Sievanen H, Huhtala H, Maki M, Kaukinen K . Gastrointestinal symptoms, quality of life and bone mineral density in mild enteropathic coeliac disease: a prospective clinical trial. Scand J Gastroenterol. 2010; 45(3):305-14. DOI: 10.3109/00365520903555879. View

van der Windt D, Jellema P, Mulder C, Kneepkens C, van der Horst H . Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010; 303(17):1738-46. DOI: 10.1001/jama.2010.549. View

Richard Locke 3rd G, Murray J, Zinsmeister A, Melton 3rd L, Talley N . Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc. 2004; 79(4):476-82. DOI: 10.4065/79.4.476. View

Carlsson A, Axelsson I, Borulf S, Bredberg A, Ivarsson S . Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics. 2001; 107(1):42-5. DOI: 10.1542/peds.107.1.42. View

Ukkola A, Maki M, Kurppa K, Collin P, Huhtala H, Kekkonen L . Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients with celiac disease. Clin Gastroenterol Hepatol. 2010; 9(2):118-23. DOI: 10.1016/j.cgh.2010.10.011. View

Spiegel B, DeRosa V, Gralnek I, Wang V, Dulai G . Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology. 2004; 126(7):1721-32. DOI: 10.1053/j.gastro.2004.03.012. View

Collin P, Reunala T, Rasmussen M, Kyronpalo S, Pehkonen E, Laippala P . High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol. 1997; 32(11):1129-33. DOI: 10.3109/00365529709002992. View

10.

Green P . The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005; 128(4 Suppl 1):S74-8. DOI: 10.1053/j.gastro.2005.02.016. View

11.

Lohi S, Maki M, Montonen J, Knekt P, Pukkala E, Reunanen A . Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut. 2008; 58(5):643-7. DOI: 10.1136/gut.2007.140970. View

12.

Fasano A . Where have all the American celiacs gone?. Acta Paediatr Suppl. 1996; 412:20-4. DOI: 10.1111/j.1651-2227.1996.tb14242.x. View

13.

Jafri M, Nordstrom C, Murray J, Van Dyke C, Dierkhising R, Zinsmeister A . Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci. 2007; 53(4):964-71. PMC: 2556244. DOI: 10.1007/s10620-007-9976-0. View

14.

Murray J, Van Dyke C, Plevak M, Dierkhising R, Zinsmeister A, Melton 3rd L . Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol. 2004; 1(1):19-27. DOI: 10.1053/jcgh.2003.50004. View

15.

Ford A, Chey W, Talley N, Malhotra A, Spiegel B, Moayyedi P . Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009; 169(7):651-8. DOI: 10.1001/archinternmed.2009.22. View

16.

Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C . The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005; 128(4 Suppl 1):S57-67. DOI: 10.1053/j.gastro.2005.02.014. View

17.

Farrell R, Kelly C . Celiac sprue. N Engl J Med. 2002; 346(3):180-8. DOI: 10.1056/NEJMra010852. View

18.

Egan L, Walsh S, Stevens F, Connolly C, Egan E, McCarthy C . Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol. 1995; 21(2):123-9. View

19.

Corazza G, Di Sario A, Sacco G, Zoli G, Treggiari E, Brusco G . Subclinical coeliac disease: an anthropometric assessment. J Intern Med. 1994; 236(2):183-7. DOI: 10.1111/j.1365-2796.1994.tb01281.x. View

20.

Catassi C, Kryszak D, Louis-Jacques O, Duerksen D, Hill I, Crowe S . Detection of Celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol. 2007; 102(7):1454-60. DOI: 10.1111/j.1572-0241.2007.01173.x. View